Bavarian Nordic's pox vaccine approved in Switzerland
Swissmedic, the regulatory authority in Switzerland, has approved Bavarian Nordic’s Jynneos (MVA-BN) for active immunization against diseases caused by smallpox, mpox and vaccinia viruses in adults aged 18 years and older, the company has announced.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.